HCAT vs SSNC
HCAT: Health Catalyst provides cloud-based data analytics and improvement services to healthcare systems, but faces significant headwinds from customer financial strain, platform migration challenges, and macroeconomic pressures on healthcare budgets. SSNC: SS&C is a leading provider of mission-critical software and outsourcing services that power the global financial services and healthcare operations infrastructure.
Side-by-side fundamentals
| Metric | HCAT | SSNC | Edge |
|---|---|---|---|
| Price as of 2026-07-27 close | $2.15 | $75.04 | |
| Market cap as of 2026-07-29 | $157M | $18.1B | |
| P/E as of 2026-07-29 | n/a | 21.58 | |
| PEG as of 2026-07-29 | -0.00 | 2.22 | HCAT lower |
| Net margin as of 2026-07-29 | -87.7% | +13.2% | SSNC higher |
| Gross margin as of 2026-07-29 | +50.4% | +48.1% | HCAT higher |
| Operating margin as of 2026-07-29 | -81.7% | +23.6% | SSNC higher |
| ROE as of 2026-07-29 | -99.8% | +12.7% | SSNC higher |
| ROA as of 2026-07-29 | -50.1% | +4.3% | SSNC higher |
| Debt / equity as of 2026-07-29 | 1.11 | 1.14 | HCAT lower |
| Revenue growth (YoY) as of 2026-07-29 | -2.8% | +8.6% | SSNC higher |
| Revenue CAGR (3y) SEC XBRL | +4.0% | +5.9% | SSNC higher |
| Dividend yield as of 2026-07-29 | n/a | +1.4% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-07-29 | 1.54 | 1.08 | |
| 1-year return as of 2026-07-27 close | -44.6% | -11.9% | SSNC higher |
Fundamentals: Finnhub, as of 2026-07-29. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-27.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.